Hamdy Ahmed MD
- SEC CIK
- 0001458506
No open-market purchases or sales filed in the past year.
Current role at each company
- CRIS Curis IncCMOas of Mar 23, 2026
- VINC Vincerx Pharma, Inc.Chief Executive Officeras of Aug 14, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hamdy Ahmed MD as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VINC Vincerx Pharma, Inc.
Chief Executive Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2023 (view filing) | Aug 9-10 | 1 day | Hamdy Ahmed MDSee Remarks | PPurchase | +22.3K | $0.9524 | +$21.2K | +30.2%96.1K after | 2 lots |
| Dec 14, 2022 (view filing) | Dec 14 | Same day | Hamdy Ahmed MDChief Executive Officer | PPurchase | +35.3K | $0.87 | +$30.7K | +91.7%73.8K after | |
| Jun 27, 2022 (view filing) | Jun 23 | 4 days | Hamdy Ahmed MDChief Executive Officer | PPurchase | +24.2K | $1.41 | +$34.1K | +169.5%38.5K after | |
| Dec 27, 2021 (view filing) | Dec 22 | 5 days | Hamdy Ahmed MDChief Executive Officer | PPurchase | +6.45K | $10.02 | +$64.6K | +82.4%14.3K after |